Case

Building Market Readiness for a Blockbuster Biotech Launch

How InnoStrat Helped a Small Biotech Company Prepare for International Growth and Phase III Success

The challenge

A small biotech company with an innovative sustained-release technology platform was preparing for its first product launch in a new therapeutic area.

With a three-year horizon to move through Phase III and hit global markets, they needed to:

Build their medical strategy from the ground up
Define what a scalable, future-ready medical affairs team should look like
Identify key unmet needs, real-world evidence gaps, and publication strategies
Ensure commercial and medical strategies were aligned early

All while operating as a lean organization with limited in-house experience across multiple functions.

Our approach

InnoStrat brought together a cross-functional team of experts in medical strategy, clinical development, commercial readiness, and global launch planning. We acted as an extended strategic arm to the biotech leadership team over 9 months, with tailored support across four key areas:

Medical Blueprint Development

We facilitated workshops and interviews with senior company leaders to co-create a full medical affairs roadmap – including a scalable MSL structure, key timelines, and priority activities.

RWE and Insight Generation

We helped map out unmet treatment needs in the targeted indication and developed a real-world evidence plan to support clinical acceptance and access discussions in key launch markets.

Publication and Communications Strategy

Working closely with clinical and scientific teams, we outlined a publication plan and proposed core medical messaging to ensure consistency across regions.

Clinical Engagement Framework

To support upcoming trials, we co-developed an engagement framework to build motivated and capable study teams at the local level – critical to ensuring recruitment and data quality.

The result

What this means for you

This case highlights how smaller organizations can gain strategic clarity and launch confidence by partnering early.

InnoStrat’s blend of clinical, medical, and commercial expertise helps teams not only plan smart – but build the capabilities to execute globally.

Feedback from our client

Medical Director ”The InnoStrat team brings the big pharma skills we need to take our novel sustained-release formulations from late-stage clinical development through to regulatory approval and launch in a new patient population.“

Medical Director ”We initially approached InnoStrat for support with our medical strategy, but it quickly became clear that they had extensive experience across the pharma value chain through to commercialization that we could leverage to secure our organizational readiness to take our product to launch within the next three years.”

Medical Director “The InnoStrat team, together with their network of expert collaborators from a regional biotech consortium, are helping us build the capacity to manage a blockbuster launch—how to set up the right organizational infrastructure at the right time with the people, knowledge, processes and tools we need to realize our business objectives.”